1. Home
  2. EIG vs SPRY Comparison

EIG vs SPRY Comparison

Compare EIG & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Employers Holdings Inc

EIG

Employers Holdings Inc

N/A

Current Price

$39.46

Market Cap

980.0M

Sector

Finance

ML Signal

N/A

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

N/A

Current Price

$8.24

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EIG
SPRY
Founded
2000
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
980.0M
1.0B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
EIG
SPRY
Price
$39.46
$8.24
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$40.00
AVG Volume (30 Days)
264.7K
996.0K
Earning Date
05-22-2026
06-12-2026
Dividend Yield
3.24%
N/A
EPS Growth
N/A
N/A
EPS
0.46
N/A
Revenue
$858,700,000.00
$84,278,000.00
Revenue This Year
N/A
$109.11
Revenue Next Year
$1.76
$91.00
P/E Ratio
$85.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$35.73
$6.66
52 Week High
$51.23
$18.63

Technical Indicators

Market Signals
Indicator
EIG
SPRY
Relative Strength Index (RSI) 40.02 35.66
Support Level $38.29 $8.05
Resistance Level $40.38 $10.44
Average True Range (ATR) 1.02 0.43
MACD -0.09 -0.04
Stochastic Oscillator 27.70 20.00

Price Performance

Historical Comparison
EIG
SPRY

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: